J Kevin Buchi, insider filing for AMRX
J Kevin Buchi, reporting
Every EDGAR filing for Amneal Pharmaceuticals, Inc. (AMRX), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 4 ยท 10-Q expected ~Nov 9 (deadline Nov 9)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
J Kevin Buchi, insider filing for AMRX
J Kevin Buchi, reporting
J Kevin Buchi, insider filing for AMRX
J Kevin Buchi, reporting
Andrew S Boyer, insider filing for AMRX
Andrew S Boyer, reporting
Andrew S Boyer, insider filing for AMRX
Andrew S Boyer, reporting
John Kiely, insider filing for AMRX
John Kiely, reporting
Nikita Shah, insider filing for AMRX
Nikita Shah, reporting
John Kiely, planned sale of AMRX shares
John Kiely, reporting
Ownership stake disclosure by Tushar Bhikhubhai Patel (amended)
Tushar Bhikhubhai Patel, filed by
Tushar Bhikhubhai Patel, insider filing for AMRX
Tushar Bhikhubhai Patel, reporting
Ownership stake disclosure by Chirag K. Patel (amended)
Chirag K. Patel, filed by
Ownership stake disclosure by Chintu Patel (amended)
Chintu Patel, filed by
Chintu Patel, insider filing for AMRX
Chintu Patel, reporting
Nikita Shah, planned sale of AMRX shares
Nikita Shah, reporting
J Kevin Buchi, planned sale of AMRX shares
J Kevin Buchi, reporting
Deborah M. Autor, insider filing for AMRX
Deborah M. Autor, reporting
Deborah M. Autor, planned sale of AMRX shares
Deborah M. Autor, reporting
J Kevin Buchi, insider filing for AMRX
J Kevin Buchi, reporting
Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by